Literature DB >> 24125786

Animal models of female sexual dysfunction: basic considerations on drugs, arousal, motivation and behavior.

Anders Ågmo1.   

Abstract

Female sexual dysfunctions are a heterogeneous group of symptoms with unknown but probably varying etiology. Social factors may contribute both to the prevalence and to the origin of these dysfunctions. The present review focuses on female hypoactive sexual desire disorder, sexual arousal disorder and orgasmic disorder. These disorders are generally the most common, according to epidemiological studies, and they can all be considered as disorders of motivation. An incentive motivational model of sexual behavior, applicable to humans as well as to non-human animals, is described and the dysfunctions placed into the context of this model. It is shown that endocrine alterations as well as observable alterations in neurotransmitter activity are unlikely causes of the disorders. A potential role of learning is stressed. Nevertheless, the role of some transmitters in female rodent sexual behavior is analyzed, and compared to data from women, whenever such data are available. The conclusion is that there is no direct coincidence between effects on rodent copulatory behavior and sexual behavior in women. Based on these and other considerations, it is suggested that sexual approach behaviors rather than copulatory reflexes in rodents might be of some relevance for human sexual behavior, and perhaps even for predicting the effects of interventions, perhaps even the effects of drugs. Female copulatory behaviors, including the proceptive behaviors, are less appropriate. The common sexual dysfunctions in women are not problems with the performance of copulatory acts, but with the desire for such acts, by feeling aroused by such acts and experiencing the pleasure expected to be caused by such acts. Finally, it is questioned whether female sexual dysfunctions are appropriate targets for pharmacological treatment.
© 2013.

Entities:  

Keywords:  Animal models; Hypoactive sexual desire disorder; Motivation; Neurotransmitters; Orgasmic disorder; Sexual arousal disorder

Mesh:

Substances:

Year:  2013        PMID: 24125786     DOI: 10.1016/j.pbb.2013.10.003

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  4 in total

1.  Use of an operant paradigm for the study of antidepressant-induced sexual dysfunction.

Authors:  Lynda Uphouse; Jonathan Pinkston; Duane Baade; Christian Solano; Bless Onaiwu
Journal:  Behav Pharmacol       Date:  2015-10       Impact factor: 2.293

2.  Establishment of Rat Model of Female Genital Sexual Arousal Disorder.

Authors:  Guangyong Li; Puguang Yu; Yanan Hu; Zhenxing Hu; Jian Li; Xuekang Zhan; Yashan Su; Chen Yu; Jing Wen; Hetao Liu; Rui He
Journal:  Sex Med       Date:  2022-05-31       Impact factor: 2.523

3.  Modeling Human Sexual Motivation in Rodents: Some Caveats.

Authors:  Olivia Le Moëne; Anders Ågmo
Journal:  Front Behav Neurosci       Date:  2019-08-27       Impact factor: 3.558

4.  Overexpressing miR-122-5p Inhibits the Relaxation of Vaginal Smooth Muscle in Female Sexual Arousal Disorder by Targeting Vasoactive Intestinal Peptide Receptor 1.

Authors:  Shengnan Cong; Tao Gui; Qinchuan Shi; Jingjing Zhang; Jingyi Feng; Lianjun Pan; Jiehua Ma; Aixia Zhang
Journal:  Sex Med       Date:  2021-07-08       Impact factor: 2.491

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.